Whalesbook
Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.[1]
Business Segments
| S.No. | Name | Current Price (Rs.) | Price to Earning | Market Capitalization (Rs.Cr.) | Dividend yield (%) | Net Profit latest quarter (Rs.Cr.) | YOY Quarterly profit growth (%) | Sales latest quarter (Rs.Cr.) | YOY Quarterly sales growth (%) | Return on capital employed (%) | Sales (Rs.Cr.) | OPM (%) | Profit after tax (Rs.Cr.) | Profit after tax latest quarter (Rs.Cr.) | Price to book value | Return on assets (%) | Debt to equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Sun Pharma.Inds. | 1818.30 | 37.81 | 436512.69 | 0.88 | 3124.95 | 2.56 | 14478.31 | 8.93 | 20.21 | 54964.01 | 30.12 | 11543.96 | 3117.95 | 5.61 | 12.97 | 0.07 |
| 2. | Divi's Lab. | 6469.00 | 69.11 | 171747.59 | 0.46 | 689.00 | 35.10 | 2715.00 | 16.12 | 20.44 | 10029.00 | 32.37 | 2485.00 | 689.00 | 11.14 | 13.53 | 0.01 |
| 3. | Torrent Pharma. | 3795.70 | 59.34 | 128559.89 | 0.84 | 591.00 | 32.49 | 3302.00 | 14.30 | 27.05 | 12248.00 | 32.60 | 2166.53 | 600.17 | 15.20 | 13.26 | 0.33 |
| 4. | Cipla | 1521.00 | 22.58 | 122853.86 | 0.85 | 1353.37 | 3.73 | 7589.44 | 7.64 | 22.72 | 28349.57 | 25.40 | 5441.14 | 1351.17 | 3.73 | 14.72 | 0.01 |
| 5. | Dr Reddy's Labs | 1277.60 | 18.48 | 106643.70 | 0.63 | 1336.80 | 7.28 | 8828.30 | 9.83 | 22.69 | 34310.00 | 24.64 | 5772.20 | 1347.10 | 2.96 | 12.95 | 0.16 |
| 6. | Lupin | 2092.00 | 22.09 | 95531.68 | 0.57 | 1484.83 | 73.34 | 7047.51 | 24.23 | 21.30 | 24750.69 | 27.25 | 4324.63 | 1477.92 | 4.87 | 12.41 | 0.32 |
| 7. | Zydus Lifesci. | 935.75 | 18.70 | 94062.77 | 1.18 | 1238.60 | 40.92 | 6123.20 | 16.92 | 24.31 | 24493.90 | 31.10 | 5029.35 | 1283.60 | 3.72 | 14.64 | 0.38 |
| 8. | Granules India | 566.40 | 38.01 | 13761.70 | 0.26 | 120.61 | 191.40 | 891.61 | 56.98 | 10.88 | 3312.04 | 19.32 | 362.03 | 120.61 | 3.87 | 5.86 | 0.29 |
| – | Median: 148 Co. | 409.77 | 31.91 | 1710.39 | 0.12 | 12.57 | 12.32 | 152.64 | 10.54 | 14.76 | 582.87 | 15.93 | 44.55 | 13.49 | 3.18 | 8.28 | 0.22 |
Standalone figures in ₹ crores
| Dec 2022 | Dec 2023 | Dec 2024 | Jun 2023 | Jun 2024 | Jun 2025 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 1,032 | 984 | 842 | 821 | 852 | 810 | 1,014 | 940 | 768 | 964 | 1,009 | 568 | 892 |
Expenses | 794 | 738 | 674 | 664 | 675 | 667 | 797 | 751 | 651 | 778 | 801 | 465 | 680 |
Operating Profit | 239 | 247 | 168 | 157 | 177 | 144 | 217 | 189 | 117 | 186 | 208 | 103 | 211 |
Other Income | -1 | 1 | 6 | 0 | 2 | 1 | 3 | 3 | 61 | 4 | 1 | 3 | 8 |
Profit before tax | 188 | 192 | 119 | 107 | 126 | 91 | 168 | 137 | 127 | 146 | 156 | 56 | 162 |
Tax % | 25% | 26% | 24% | 25% | 25% | 24% | 25% | 29% | 26% | 25% | 26% | 26% | 26% |
Net Profit | 140 | 143 | 90 | 80 | 94 | 69 | 125 | 97 | 94 | 109 | 116 | 41 | 121 |
EPS in Rs | 5.78 | 5.89 | 3.72 | 3.30 | 3.87 | 2.86 | 5.18 | 4.01 | 3.88 | 4.39 | 4.79 | 1.71 | 4.97 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 990 | 1,213 | 1,328 | 1,349 | 1,647 | 2,098 | 2,310 | 3,135 | 3,238 | 3,931 | 3,755 | 3,030 | 3,312 |
Expenses | 826 | 1,001 | 1,058 | 1,054 | 1,353 | 1,766 | 1,816 | 2,273 | 2,589 | 3,092 | 2,951 | 2,464 | 2,672 |
Operating Profit | 163 | 212 | 270 | 296 | 294 | 333 | 494 | 862 | 649 | 840 | 804 | 567 | 640 |
Other Income | 3 | 1 | 6 | 15 | 24 | 28 | 187 | 13 | 13 | 9 | 3 | 70 | 76 |
Interest | 19 | 31 | 37 | 32 | 33 | 28 | 27 | 24 | 16 | 39 | 72 | 63 | 61 |
Depreciation | 26 | 50 | 58 | 71 | 76 | 91 | 102 | 118 | 126 | 146 | 144 | 146 | 156 |
Profit before tax | 121 | 132 | 181 | 207 | 208 | 242 | 553 | 733 | 520 | 664 | 591 | 427 | 499 |
Net Profit | 81 | 95 | 121 | 143 | 139 | 162 | 444 | 553 | 387 | 499 | 436 | 319 | 374 |
EPS in Rs | 3.99 | 4.66 | 5.57 | 6.25 | 5.48 | 6.37 | 17.47 | 22.32 | 15.59 | 20.61 | 17.99 | 13.17 | 15.43 |
Dividend Payout % | 9% | 11% | 12% | 14% | 18% | 16% | 6% | 7% | 10% | 7% | 8% | 11% | – |
Standalone figures in ₹ crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 20 | 20 | 22 | 23 | 25 | 25 | 25 | 25 | 25 | 24 | 24 | 24 | 24 |
Reserves | 324 | 405 | 643 | 861 | 1,253 | 1,398 | 1,786 | 2,138 | 2,506 | 2,675 | 3,087 | 3,379 | 3,524 |
Borrowings | 330 | 412 | 641 | 656 | 978 | 991 | 891 | 849 | 1,061 | 923 | 1,065 | 899 | 1,014 |
Other Liabilities | 181 | 270 | 262 | 314 | 382 | 410 | 444 | 672 | 781 | 881 | 830 | 850 | 881 |
Total Liabilities | 856 | 1,107 | 1,568 | 1,855 | 2,639 | 2,824 | 3,146 | 3,683 | 4,373 | 4,503 | 5,006 | 5,152 | 5,443 |
Fixed Assets | 336 | 522 | 523 | 606 | 660 | 700 | 927 | 985 | 1,171 | 1,330 | 1,324 | 1,405 | 1,423 |
Gross Block | 473.52 | 725.69 | 784.53 | 937.36 | 1,065.65 | 1,195.01 | 1,522.83 | 1,693.02 | 1,949.12 | 2,200.71 | 2,312.27 | 2,499.41 | – |
Accumulated Depreciation | 137.84 | 203.53 | 261.24 | 331.78 | 405.50 | 495.06 | 595.94 | 708.02 | 778.29 | 870.91 | 988.60 | 1,094.41 | – |
CWIP | 39 | 18 | 35 | 132 | 286 | 333 | 130 | 164 | 211 | 63 | 53 | 121 | 119 |
Investments | 145 | 72 | 89 | 75 | 75 | 506 | 445 | 592 | 597 | 677 | 941 | 1,282 | 1,547 |
Other Assets | 336 | 494 | 920 | 1,042 | 1,618 | 1,285 | 1,644 | 1,942 | 2,395 | 2,433 | 2,688 | 2,345 | 2,355 |
Total Assets | 856 | 1,107 | 1,568 | 1,855 | 2,639 | 2,824 | 3,146 | 3,683 | 4,373 | 4,503 | 5,006 | 5,152 | 5,443 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operating Activity | 94 | 135 | 144 | 190 | 24 | 227 | 495 | 375 | 280 | 664 | 317 | 823 |
Cash from Investing Activity | -159 | -130 | -171 | -299 | -495 | -243 | -165 | -233 | -318 | -97 | -302 | -554 |
Cash from Financing Activity | 80 | 25 | 86 | 36 | 529 | -17 | -212 | -296 | 151 | -519 | 26 | -340 |
Net Cash Flow | 16 | 30 | 58 | -73 | 58 | -33 | 118 | -154 | 114 | 48 | 41 | -71 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 45 | 58 | 122 | 127 | 154 | 122 | 99 | 118 | 136 | 127 | 159 | 156 |
Inventory Days | 75 | 93 | 105 | 132 | 92 | 92 | 103 | 112 | 123 | 100 | 111 | 176 |
Days Payable | 79 | 95 | 89 | 116 | 105 | 81 | 96 | 123 | 126 | 126 | 125 | 167 |
Cash Conversion Cycle | 41 | 56 | 139 | 142 | 140 | 133 | 105 | 107 | 133 | 102 | 144 | 166 |
Working Capital Days | 21 | 12 | 16 | 5 | 50 | 53 | 56 | 59 | 49 | 48 | 62 | 62 |
ROCE % | 24% | 22% | 20% | 17% | 13% | 12% | 16% | 26% | 16% | 20% | 17% | 11% |
Direct from BSE filings, auto-summarised
External media mentions & references
Editorial & research coverage
Nov 2025
Aug 2025
Jun 2025
Jan 2025
Nov 2024
Aug 2024
May 2024
Jan 2024
Nov 2023
Aug 2023
May 2023
Jan 2023
Oct 2022
Aug 2022
May 2022
Feb 2022
Nov 2021
Jul 2021
Jun 2021
May 2021
May 2021
Jan 2021
Oct 2020
Jul 2020
Jun 2020
Jan 2020
Dec 2019
Oct 2019
Jul 2019
May 2019
Jan 2019
Oct 2018
Jul 2018
May 2018
Feb 2018
Nov 2017
Aug 2017
May 2017
Jan 2017
Nov 2016
Aug 2016
Apr 2016
Jan 2016
